Literature DB >> 11119298

Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer.

G E Airewele1, A J Sigurdson, K J Wiley, B E Frieden, L W Caldarera, V M Riccardi, R A Lewis, M M Chintagumpala, J L Ater, S E Plon, M L Bondy.   

Abstract

The risk of malignancies among persons with neurofibromatosis 1 (NF1) is higher than in the general population, but the excess risk has not been precisely estimated. The effects of gender and inheritance pattern on cancer risk are unclear. Therefore, we conducted a historical cohort study to determine cancer risk factors by contacting 138 Caucasian NF1 patients originally seen at Baylor College of Medicine (BCM) in Houston between 1978 and 1984. A total of 304 patients of all ethnic groups were evaluated at BCM during this period. We successfully located 173 patients, 138 of who were Caucasian. We computed standardized incidence ratios (SIRs) with the age-, gender-, and time period-specific rates from the Connecticut Tumor Registry for 2,094 person-years of observation (median follow-up = 16 years). Eleven incident tumors were reported. Females were at much higher risk of cancer than males (SIR = 5.6, 95% confidence interval (CI) 2.7-10.3 and SIR = 0.6; 95% CI, 0.0-3.0, respectively). We found no elevated cancer risk in unaffected first-degree relatives, regardless of whether the proband had cancer or not (SIR = 1.1 95% CI, 0.6-1.8 and SIR = 1.0, 95% CI, 0.6-1.5, respectively). Our results suggest that malignancy in the proband is not the result of a modifying gene that has a significant impact on general cancer risk. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11119298     DOI: 10.1002/1098-2272(200101)20:1<75::AID-GEPI7>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  7 in total

1.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

2.  Natural history and management of low-grade glioma in NF-1 children.

Authors:  Pablo Hernáiz Driever; Stephan von Hornstein; Torsten Pietsch; Rolf Kortmann; Monika Warmuth-Metz; Angela Emser; Astrid K Gnekow
Journal:  J Neurooncol       Date:  2010-03-30       Impact factor: 4.130

3.  Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.

Authors:  Salmafatima S Abadin; Nancy L Zoellner; Melody Schaeffer; Bree Porcelli; David H Gutmann; Kimberly J Johnson
Journal:  J Pediatr       Date:  2015-05-28       Impact factor: 4.406

4.  Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

Authors:  S A Rasmussen; Q Yang; J M Friedman
Journal:  Am J Hum Genet       Date:  2001-03-28       Impact factor: 11.025

Review 5.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.

Authors:  S Sharif; A Moran; S M Huson; R Iddenden; A Shenton; E Howard; D G R Evans
Journal:  J Med Genet       Date:  2007-03-16       Impact factor: 6.318

7.  Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).

Authors:  Maria Masocco; Yllka Kodra; Monica Vichi; Susanna Conti; Mark Kanieff; Monica Pace; Luisa Frova; Domenica Taruscio
Journal:  Orphanet J Rare Dis       Date:  2011-03-25       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.